1
|
De Marco S, Torsello B, Morabito I, Bombelli S, Grasselli C, Zucchini N, Lucarelli G, Strada G, Perego R, Bianchi C. ABL2 kinase is involved in TGFB1-induced matrix degradation by invadopodia in clear cell renal cell carcinoma. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)01305-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
2
|
Marchioni M, Porreca A, Di Nicola M, Lucarelli G, Dorin V, Soria F, Terracciano D, Mistretta F, Buonerba C, Cantiello F, Cantiello F, Mari A, Minervini A, Veccia A, Musi G, Hurle R, Busetto G, Del Giudice F, Chung B, Berardinelli F, Perdonà S, Del Prete P, Mirone V, Borghesi M, Porreca A, Bove P, Autorino R, Crisan N, Battaglia M, Ditonno P, Russo G, Muto M, Damiano R, Porpiglia F, de Cobelli O, Schips L, Ferro M. Progression-free survival as surrogate endpoint in high-risk non-muscle invasive bladder cancer studies: results from a machine learning-based analysis of a large multi-institutional database. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)01228-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
|
3
|
Loizzo D, Pandolfo S, Beksac A, Derweesh I, Celia A, Schiavina R, Napolitano L, Longo N, Bianchi L, Kaouk J, Capitanio U, Basile G, Mirone V, Del Giudice F, Ditonno P, Lucarelli G, Autorino R. Robot-assisted partial nephrectomy versus percutaneous thermal ablation for renal mass in solitary kidney: a multicenter analysis. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)01302-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
|
4
|
Soria F, Pradere B, Hurle R, D'Andrea D, Albisinni S, Diamand R, Laukhtina E, Di Trapani E, Aziz A, Krajewski W, Teoh J, Mari A, Moschini M, Chiancone F, Autorino R, Porreca A, Marchioni M, Liguori G, Lucarelli G, Busetto G, Foschi N, Antonelli A, Bove P, Russo G, Crisan N, Borghesi M, Boeri L, Veccia A, Greco F, Longo N, De Cobelli O, Shariat S, Gontero P, Ferro M. Radical Nephroureterectomy Tetrafecta: A Proposal Reporting Surgical Strategy Quality at Surgery. EUR UROL SUPPL 2022; 42:1-8. [PMID: 35911084 PMCID: PMC9334825 DOI: 10.1016/j.euros.2022.05.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/27/2022] [Indexed: 11/22/2022] Open
Abstract
Background Standardized methods for reporting surgical quality have been described for all the major urological procedures apart from radical nephroureterectomy (RNU). Objective To propose a tetrafecta criterion for assessing the quality of RNU based on a consensus panel within the Young Association of Urology (YAU) Urothelial Group, and to test the impact of this tetrafecta in a multicenter, large contemporary cohort of patients treated with RNU for upper tract urothelial carcinoma (UTUC). Design, setting, and participants This was a retrospective analysis of 1765 patients with UTUC treated between 2000 and 2021. Outcome measurements and statistical analysis We interviewed the YAU Urothelial Group to propose and score a list of items to be included in the “RNU-fecta.” A ranking was generated for the criteria with the highest sum score. These criteria were applied to a large multicenter cohort of patients. Kaplan-Meier curves were built to evaluate differences in overall survival (OS) rates between groups, and a multivariable logistic regression model was used to find the predictors of achieving the RNU tetrafecta. Results and limitations The criteria with the highest score included three surgical items such as negative soft tissue surgical margins, bladder cuff excision, lymph node dissection according to guideline recommendations, and one oncological item defined by the absence of any recurrence in ≤12 mo. These items formed the RNU tetrafecta. Within a median follow-up of 30 mo, 52.6% of patients achieved the RNU tetrafecta. The 5-yr OS rates were significantly higher for patients achieving tetrafecta than for their counterparts (76% vs 51%). Younger age, lower body mass index, and robotic approach were found to be independent predictors of tetrafecta achievement. Conversely, a higher Eastern Cooperative Oncology Group score, higher clinical stage, and bladder cancer history were inversely associated with tetrafecta. Conclusions Herein, we present a “tetrafecta” composite endpoint that may serve as a potential tool to assess the overall quality of the RNU procedure. Pending external validation, this tool could allow a comparison between surgical series and may be useful for assessing the learning curve of the procedure as well as for evaluating the impact of new technologies in the field. Patient summary In this study, a tetrafecta criterion was developed for assessing the surgical quality of radical nephroureterectomy in patients with upper tract urothelial carcinoma. Patients who achieved tetrafecta had higher 5-yr overall survival rates than those who did not.
Collapse
|
5
|
Laforgia M, Amodio L, Colangiulo S, Ungaro V, Gatti L, Lucarelli G, Leopoldo M, Nardulli P, Colabufo NA. LC-MS/MS Analysis on Infusion Bags and Filled Syringes of Decitabine: New Data on Physicochemical Stability of an Unstable Molecule. ACS Omega 2022; 7:25239-25243. [PMID: 35910137 PMCID: PMC9330129 DOI: 10.1021/acsomega.2c02144] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/06/2022] [Accepted: 07/01/2022] [Indexed: 06/01/2023]
Abstract
Many anticancer drugs are reported to have low physicochemical stability after dilution; therefore, producers impose short times from reconstitution, dilution, and the end of administration. The precariousness of cancer patients' health in real-life experience within cancer hospitals often forces delays in the drug administration with respect to the standard treatment schedule timing, because of acute toxicities or the need to postpone a control analysis before administration. The public health costs for discarded anticancer drugs due to administration interruptions can be avoided, thanks to independent analytical studies, which integrate the producer's data reported in the technical sheet, referring to the real conditions of preparation in a sterile atmosphere under a cabin in a laboratory dedicated to handling cytotoxic drugs in controlled conditions of temperature, pressure, and particulate contamination. Decitabine is apparently an unstable molecule, whose reported stability is only 3 h at 2-8 °C when diluted, while the mother solution must be immediately used or, otherwise, discarded. This study has investigated the physicochemical stability of decitabine both in diluted infusion bags and in sterile water reconstituted syringes at 4 °C for 0, 24, 48, and 72 h. In all performed studies, the stability-indicating method involves, for the first time, the use of liquid chromatography-tandem mass spectrometry analysis. Unexpectedly, both diluted and reconstituted solutions of decitabine are more stable than previously reported data, with a 48 h-long physicochemical stability at 2-8 °C and protected from light.
Collapse
Affiliation(s)
- Mariarita Laforgia
- S.C.
Farmacia e U.Ma.C.A. IRCCS Istituto Tumori “Giovanni Paolo
II”, Viale Orazio
Flacco, Bari 70124, Italy
| | - Loredana Amodio
- Biofordrug, Spin-Off
of Bari University, Via
Dante, Triggiano, Bari 70019, Italy
| | - Santina Colangiulo
- Biofordrug, Spin-Off
of Bari University, Via
Dante, Triggiano, Bari 70019, Italy
| | - Valentina Ungaro
- S.C.
Farmacia e U.Ma.C.A. IRCCS Istituto Tumori “Giovanni Paolo
II”, Viale Orazio
Flacco, Bari 70124, Italy
| | - Letizia Gatti
- S.C.
Farmacia e U.Ma.C.A. IRCCS Istituto Tumori “Giovanni Paolo
II”, Viale Orazio
Flacco, Bari 70124, Italy
| | - Gianpiero Lucarelli
- S.C.
Farmacia e U.Ma.C.A. IRCCS Istituto Tumori “Giovanni Paolo
II”, Viale Orazio
Flacco, Bari 70124, Italy
| | - Marcello Leopoldo
- Biofordrug, Spin-Off
of Bari University, Via
Dante, Triggiano, Bari 70019, Italy
- Department
of Pharmacy-Drug Sciences, University of
Bari “Aldo Moro”, Via Orabona, Bari 70121, Italy
| | - Patrizia Nardulli
- S.C.
Farmacia e U.Ma.C.A. IRCCS Istituto Tumori “Giovanni Paolo
II”, Viale Orazio
Flacco, Bari 70124, Italy
| | - Nicola A. Colabufo
- Biofordrug, Spin-Off
of Bari University, Via
Dante, Triggiano, Bari 70019, Italy
- Department
of Pharmacy-Drug Sciences, University of
Bari “Aldo Moro”, Via Orabona, Bari 70121, Italy
| |
Collapse
|
6
|
Soria F, Hurle R, D’Andrea D, Albisinni S, Laukhtina E, Pradere B, Di Trapani E, Aziz A, Krajewski W, Teoh J, Mari A, Moschini M, Autorino R, Porreca A, Marchioni M, Liguori G, Lucarelli G, Busetto G, Antonelli A, Russo G, Crisan N, Veccia A, De Cobelli O, Gontero P, Ferro M. Radical nephroureterectomy pentafecta: A proposal for standardisation of oncologic outcomes reporting following open, laparoscopic or robot-assisted radical nephroureterectomy. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)01168-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
7
|
Vitarelli A, Pagliarulo V, De Rienzo G, Minafra P, Lucarelli G, Battaglia M, Ditonno P. Robot-assisted radical perineal prostatectomy: one-year functional and oncological outcomes. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35591-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
8
|
Lucarelli G, Netti G, Spadaccino F, Castellano G, Gigante M, Divella C, Rocchetti M, Rascio F, Stallone G, Carrieri G, Gesualdo L, Battaglia M, Ranieri E. La Pentraxina 3 (PTX3) Modula l’immunoflogosi nel microambiente tumorale ed è un fattore prognostico in pazienti con carcinoma renale a cellule chiare. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35398-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
9
|
Busetto G, Del Giudice F, Maggi M, Romagnoli D, D’Agostino D, Del Rosso A, Corsi P, Colicchia M, Lucarelli G, Ferro M, de Cobelli O, Sciarra A, De Berardinis E, Porreca A. Surgical blood loss during holmium laser enucleation of the prostate (HoLEP) is not affected by short-term pretreatment with dutasteride: a double-blind placebo-controlled trial on prostate vascularity. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)35450-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
10
|
De Rienzo G, Lorusso A, Zingarelli M, Minafra P, Di Modugno F, Procacci A, Lucarelli G, Battaglia M, Ditonno P. Transperineal laser ablation of prostate. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)34235-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
11
|
Porreca A, Del Giudice F, Giampaoli M, D’Agostino D, Romagnoli D, Del Rosso A, Corsi P, Maggi M, Ferro M, De Cobelli O, Lucarelli G, Schiavina R, De Berardinis E, Sciarra A, Busetto G. Adding systematic biopsy (SBx) to magnetic resonance ultrasound fusion targeted biopsy (TBx) of the prostate in men with previous negative biopsy or enrolled in active surveillance programs: A prospective single center, randomized, analysis. EUR UROL SUPPL 2020. [DOI: 10.1016/s2666-1683(20)32665-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
12
|
Pratesi A, Baldasseroni S, Stefano P, Del Pace S, Campagnolo V, Baroncini AC, Lo Forte A, Carrassi E, Ghiara C, Lucarelli G, Marella AJ, Orso F, Ungar A, Marchionni N, Di Bari M. P5983Pre-operative physical performance as an independent predictor of in-hospital outcomes in older patients undergoing elective cardiac surgery. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0704] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
Risk stratification of patients candidate to cardiac surgery is usually based on the Society of Thoracic Surgeons (STS) score or on the Euroscore II. However, these risk scores has limited predictive value in elderly patients.
Purpose
We conducted a study to determine whether the Short Physical Performance Battery (SPPB), a tool assessing physical performance, predicts hospital death and major morbidity, beyond STS risk score. The outcome was a composite end-point as defined by STS Major Morbidity or Operative Mortality (STS-MM) in STS Risk Model Outcomes: operative mortality, stroke, renal failure, prolonged mechanical ventilation, deep sternal wound infection, and reoperation.
Methods
In this prospective, single-center, cohort, hospital-based study, conducted at Careggi University Hospital, Florence, Italy, all patients aged 75+ years referred for an elective coronary aortic by-pass grafting, valvular surgery or combined cardiac surgery were evaluated pre-operatively. Assessment included SPPB, cognitive and functional status and evaluation of comorbidity. Patients receiving emergency/urgent cardiac surgery or a procedure not considered in the STS risk score calculator, who reported previous cardiac surgery or were clinically unstable were excluded. Participants were classified according to the STS-Predicted Risk Of Mortality (STS-PROM) as at low (<4%), intermediate (4 to 8%) or high risk (>8%).
Results
Out of 250 participants (females: 48.4%; mean age: 79.9 years), 148 (59.2%) were at low, 73 (29.2%) at intermediate and 29 (11.6%) at high risk, based on the STS-PROM. Mean±SEM SPPB score was 8.8±0.2, 7.1±0.4 and 6.0±0.7 in participants at low, intermediate, and high risk, respectively (p<0.001). The outcome occurred in 67 subjects (26.8%). SPPB score predicted the outcome in the entire study sample, controlling for STS-MM score, CKD, and anaemia (adjusted OR: 0.89, 95% CI 0.81–0.98 per each point increase; p 0.017). When analyses were repeated separately in participants with STS-PROM indicative of low (<4%) and in those at medium-high risk, the predictive value of SPPB was enhanced in the formers (adjusted OR 0.73, 95% CI 0.62–0.86 per each point increase; p<0.001- controlling for STS score), whereas was lost in the latter. An alternative model was subsequently tested, where STS score was not included and peripheral artery disease and creatinine (variables contributing to the STS score) were individually entered: SPPB was confirmed as a significant predictor also in this model, controlling for anaemia, peripheral artery disease, and creatinine. The corresponding AUC was 0.813 (Figure 1).
Figure 1
Conclusions
SPPB predicts mortality and major morbidity in older patients undergoing elective cardiac surgery, in particular in those classified as low-risk with the STS risk score. Use of SPPB should therefore be recommended to improve preoperative risk stratification of older patients.
Collapse
Affiliation(s)
- A Pratesi
- Careggi University Hospital (AOUC), Department of Experimental and Clinical Medicine, Florence, Italy
| | - S Baldasseroni
- Careggi University Hospital (AOUC), Unit of Geriatrics, Department of Medicine and Geriatrics, Florence, Italy
| | - P Stefano
- Careggi University Hospital (AOUC), Cardiac Surgery Unit, Cardio-Thoracic-Vascular Department, Florence, Italy
| | - S Del Pace
- Careggi University Hospital (AOUC), General Cardiology, Cardio-Thoracic-Vascular Department, Florence, Italy
| | - V Campagnolo
- Careggi University Hospital (AOUC), Cardiac Anesthesiology Unit, Cardio-Thoracic-Vascular Department, Florence, Italy
| | - A C Baroncini
- Careggi University Hospital (AOUC), Department of Experimental and Clinical Medicine, Florence, Italy
| | - A Lo Forte
- Careggi University Hospital (AOUC), Department of Experimental and Clinical Medicine, Florence, Italy
| | | | - C Ghiara
- Careggi University Hospital (AOUC), Department of Experimental and Clinical Medicine, Florence, Italy
| | - G Lucarelli
- Careggi University Hospital (AOUC), Department of Experimental and Clinical Medicine, Florence, Italy
| | - A J Marella
- Careggi University Hospital (AOUC), Unit of Geriatrics, Department of Medicine and Geriatrics, Florence, Italy
| | - F Orso
- Careggi University Hospital (AOUC), Unit of Geriatrics, Department of Medicine and Geriatrics, Florence, Italy
| | - A Ungar
- Careggi University Hospital (AOUC), Department of Experimental and Clinical Medicine, Florence, Italy
| | - N Marchionni
- Careggi University Hospital (AOUC), Department of Experimental and Clinical Medicine, Florence, Italy
| | - M Di Bari
- Careggi University Hospital (AOUC), Department of Experimental and Clinical Medicine, Florence, Italy
| |
Collapse
|
13
|
Ferro M, Di Lorenzo G, Vartolomei MD, Bruzzese D, Cantiello F, Lucarelli G, Musi G, Di Stasi S, Hurle R, Guazzoni G, Busetto GM, Gabriele A, Del Giudice F, Damiano R, Perri F, Perdona S, Verze P, Borghesi M, Schiavina R, Almeida GL, Bove P, Lima E, Autorino R, Crisan N, Farhan ARA, Battaglia M, Russo GI, Ieluzzi V, Morgia G, De Placido P, Terracciano D, Cimmino A, Scafuri L, Mirone V, De Cobelli O, Shariat S, Sonpavde G, Buonerba C. Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor. World J Urol 2019; 38:143-150. [PMID: 30993426 DOI: 10.1007/s00345-019-02754-2] [Citation(s) in RCA: 45] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2019] [Accepted: 04/01/2019] [Indexed: 01/28/2023] Open
Abstract
BACKGROUND Basophils, eosinophils and monocytes may be involved in BCG-induced immune responses and be associated with outcomes of bladder cancer patients receiving intravesical BCG. Our objective was to explore the association of baseline counts of basophils, eosinophils and monocytes with outcomes of patients with high-grade T1 bladder cancer receiving a standard course of intravesical BCG. METHODS We retrospectively reviewed medical records of patients with primary T1 HG/G3 bladder cancer. After re-TURBT, patients were treated with a 6-week course of intravesical BCG induction followed by intravesical BCG every week for 3 weeks given at 3, 6, 12, 18, 24, 30 and 36 months from initiation of therapy The analysis of potential risk factors for recurrence, muscle invasion and cancer-specific and overall survival was performed using univariable Cox regression models. Those factors that presented, at univariate analysis, an association with the event at a liberal p < 0.1, have been selected for the development of a multivariable model. RESULTS A total of 1045 patients with primary T1 HG/G3 were included. A total of 678 (64.9%) recurrences, 303 (29.0%) progressions and 150 (14.3%) deaths were observed during follow-up. Multivariate analysis showed that logarithmic transformation of basophils count was associated with a 30% increment in the hazard of recurrence per unit increase of logarithmic basophils count (HR 1.30; 95% confidence interval 1.09-1.54; p = 0.0026). Basophil count modeled by quartiles was also significantly associated with time to recurrence [second vs. lower quartile HR 1.42 (1.12-1.79); p = 0.003, third vs. lower quartile HR 1.26 (1.01-1.57); p = 0.041; upper vs. lower quartile HR 1.36 (1.1-1.68); p = 0.005]. The limitations of a retrospective study are applicable. CONCLUSION Baseline basophil count may predict recurrence in BCG-treated HG/G3 T1 bladder cancer patients. External validation is warranted.
Collapse
Affiliation(s)
- M Ferro
- Division of Urology, European Institute of Oncology, via Ripamonti 435, Milan, Italy.
| | - G Di Lorenzo
- Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy.,Department of Medicine, Università degli Studi del Molise, Campobasso, Italy
| | - M D Vartolomei
- Division of Urology, European Institute of Oncology, via Ripamonti 435, Milan, Italy.,Department of Cell and Molecular Biology, University of Medicine and Pharmacy, Tirgu Mures, Romania
| | - D Bruzzese
- Department of Public Health, Federico II University of Naples, Naples, Italy
| | - F Cantiello
- Department of Urology, Magna Graecia University of Catanzaro, Catanzaro, Italy
| | - G Lucarelli
- Department of Emergency and Organ Transplantation, Urology, Andrology and Kidney Transplantation Unit, University of Bari, Bari, Italy
| | - G Musi
- Division of Urology, European Institute of Oncology, via Ripamonti 435, Milan, Italy
| | - S Di Stasi
- Department of Experimental Medicine and Surgery, Tor Vegata University, Rome, Italy
| | - R Hurle
- Department of Urology, Istituto Clinico Humanitas Istituto di Ricovero e Cura a Carattere Scientifico-Clinical and Research Hospital, Milan, Italy
| | - G Guazzoni
- Department of Biomedical Science, Humanitas University, Milan, Rozzano, Italy
| | - G M Busetto
- Department of Urology, Sapienza University of Rome, Rome, Italy
| | - A Gabriele
- Department of Urology, Sapienza University of Rome, Rome, Italy
| | - F Del Giudice
- Department of Urology, Sapienza University of Rome, Rome, Italy
| | - R Damiano
- Department of Urology, Magna Graecia University of Catanzaro, Catanzaro, Italy
| | - F Perri
- Uro-Gynecological Department, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione "G. Pascale" IRCCS, Naples, Italy
| | - S Perdona
- Uro-Gynecological Department, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione "G. Pascale" IRCCS, Naples, Italy
| | - P Verze
- Department of Neurosciences, Sciences of Reproduction and Odontostomatology, Urology Unit, University of Naples "Federico II", Naples, Italy
| | - M Borghesi
- Department of Urology, University of Bologna, Bologna, Italy
| | - R Schiavina
- Department of Urology, University of Bologna, Bologna, Italy
| | - G L Almeida
- Departamento de Urologia, University of Vale do Itajaí, Itajaí, Brazil
| | - P Bove
- Division of Urology, Department of Experimental Medicine and Surgery, Urology Unit, Tor Vergata University of Rome, Rome, Italy
| | - E Lima
- Life and Health Sciences Research Institute, University of Minho, Braga, Portugal
| | - R Autorino
- Division of Urology, Virginia Commonwealth University, Richmond, VA, USA
| | - N Crisan
- Department of Urology, University of Medicine and Pharmacy "Iuliu Haţeganu,", Cluj-Napoca, Romania
| | - A R Abu Farhan
- Department of Urology, Magna Graecia University of Catanzaro, Catanzaro, Italy
| | - M Battaglia
- Department of Emergency and Organ Transplantation, Urology, Andrology and Kidney Transplantation Unit, University of Bari, Bari, Italy
| | - G I Russo
- Department of Urology, University of Catania, Catania, Italy
| | - Vincenzo Ieluzzi
- Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy
| | - G Morgia
- Department of Urology, University of Catania, Catania, Italy
| | - P De Placido
- Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy
| | - D Terracciano
- Department of Translational Medical Sciences, University of Naples "Federico II", Naples, Italy
| | - A Cimmino
- Institute of Genetics and Biophysics "A. Buzzati-Traverso", CNR, Naples, Italy
| | - L Scafuri
- Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy
| | - V Mirone
- Department of Neurosciences, Sciences of Reproduction and Odontostomatology, Urology Unit, University of Naples "Federico II", Naples, Italy
| | - O De Cobelli
- Division of Urology, European Institute of Oncology, via Ripamonti 435, Milan, Italy
| | - S Shariat
- Department of Urology, Medical University of Vienna, Vienna, Austria
| | - Guru Sonpavde
- Dana-Farber Cancer Institute, GU Oncology Division, Harvard Medical School, Boston, MA, USA
| | - C Buonerba
- Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy.,Zoo-prophylactic Institute of Southern Italy, Portici, Italy
| |
Collapse
|
14
|
Simone S, De Palma G, Stasi A, Curci C, Franzin R, Accetturo M, Rutigliano M, Lucarelli G, Battaglia M, Gallone A, Grandaliano G, Castellano G, Gesualdo L, Pertosa G, Sallustio F. FP025THE ROLE OF LONG NON-CODING RNAS IN THE REGULATION OF ADULT RENAL STEM/PROGENITOR CELLS (ARPCS) FUNCTIONS. Nephrol Dial Transplant 2018. [DOI: 10.1093/ndt/gfy104.fp025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- S Simone
- Nephrology Unit, DETO, University of Bari, Bari, Italy
| | - G De Palma
- Nephrology Unit, DETO, University of Bari, Bari, Italy
| | - A Stasi
- Nephrology Unit, DETO, University of Bari, Bari, Italy
| | - C Curci
- Nephrology Unit, DETO, University of Bari, Bari, Italy
| | - R Franzin
- Nephrology Unit, DETO, University of Bari, Bari, Italy
| | - M Accetturo
- Nephrology Unit, DETO, University of Bari, Bari, Italy
| | - M Rutigliano
- Andrology and Kidney Transplantation Unit, DETO, University of Bari, Bari, Italy
| | - G Lucarelli
- Andrology and Kidney Transplantation Unit, DETO, University of Bari, Bari, Italy
| | - M Battaglia
- Andrology and Kidney Transplantation Unit, DETO, University of Bari, Bari, Italy
| | - A Gallone
- SMBNOS, University of Bari, Bari, Italy
| | - G Grandaliano
- Medical and Surgical Sciences, University of Foggia, Bari, Italy
| | - G Castellano
- Nephrology Unit, DETO, University of Bari, Bari, Italy
| | - L Gesualdo
- Nephrology Unit, DETO, University of Bari, Bari, Italy
| | | | | |
Collapse
|
15
|
Sallustio F, Stasi A, Curci C, Franzin R, Picerno A, Divella C, Laghetti P, De Palma G, Accetturo M, Rutigliano M, Lucarelli G, Battaglia M, Pertosa GB, Gallone A, Gesualdo L, Castellano G. FP211A CLUSTER OF PROTEINS SECRETED BY HUMAN RENAL STEM/PROGENITOR CELLS (ARPCS) PROVIDE A NOVEL STRATEGY TO REVERT ENDOTHELIAL DYSFUNCTION AND RENAL INJURY IN SEPSIS-INDUCED ACUTE KIDNEY INJURY (AKI). Nephrol Dial Transplant 2018. [DOI: 10.1093/ndt/gfy104.fp211] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- F Sallustio
- Nephrology Unit, DETO, University of Bari, Bari, Italy
| | - A Stasi
- Nephrology Unit, DETO, University of Bari, Bari, Italy
| | - C Curci
- Nephrology Unit, DETO, University of Bari, Bari, Italy
| | - R Franzin
- Nephrology Unit, DETO, University of Bari, Bari, Italy
| | - A Picerno
- Nephrology Unit, DETO, University of Bari, Bari, Italy
| | - C Divella
- Nephrology Unit, DETO, University of Bari, Bari, Italy
| | - P Laghetti
- Nephrology Unit, DETO, University of Bari, Bari, Italy
| | - G De Palma
- Nephrology Unit, DETO, University of Bari, Bari, Italy
| | - M Accetturo
- Nephrology Unit, DETO, University of Bari, Bari, Italy
| | - M Rutigliano
- Andrology and Kidney Transplant Unit, DETO, University of Bari, Bari, Italy
| | - G Lucarelli
- Andrology and Kidney Transplant Unit, DETO, University of Bari, Bari, Italy
| | - M Battaglia
- Andrology and Kidney Transplant Unit, DETO, University of Bari, Bari, Italy
| | - G B Pertosa
- Nephrology Unit, DETO, University of Bari, Bari, Italy
| | - A Gallone
- SMBNOS, University of Bari, Bari, Italy
| | - L Gesualdo
- Nephrology Unit, DETO, University of Bari, Bari, Italy
| | - G Castellano
- Nephrology Unit, DETO, University of Bari, Bari, Italy
| |
Collapse
|
16
|
Curci C, Chaoul N, Picerno A, De Palma G, Laghetti P, Stasi A, Franzin R, Rutigliano M, Lucarelli G, Battaglia M, Pertosa GB, Gallone A, Castellano G, Gesualdo L, Sallustio F. SaO053ADULT RENAL STEM/PROGENITOR CELLS (ARPCS) HAVE AN IMMUNOMODULATORY EFFECT ON T REGULATORY CELLS (TREGS) AND DOUBLE NEGATIVE (DN) T CELLS. Nephrol Dial Transplant 2018. [DOI: 10.1093/ndt/gfy104.sao053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- C Curci
- Nephrology Unit, DETO, University of Bari, Bari, Italy
| | - N Chaoul
- Allergology Unit, DETO, University of Bari, Bari, Italy
| | - A Picerno
- Nephrology Unit, DETO, University of Bari, Bari, Italy
| | - G De Palma
- Nephrology Unit, DETO, University of Bari, Bari, Italy
| | - P Laghetti
- Nephrology Unit, DETO, University of Bari, Bari, Italy
| | - A Stasi
- Nephrology Unit, DETO, University of Bari, Bari, Italy
| | - R Franzin
- Nephrology Unit, DETO, University of Bari, Bari, Italy
| | - M Rutigliano
- Andrology and Kidney Transplantation Unit, DETO, University of Bari, Bari, Italy
| | - G Lucarelli
- Andrology and Kidney Transplantation Unit, DETO, University of Bari, Bari, Italy
| | - M Battaglia
- Andrology and Kidney Transplantation Unit, DETO, University of Bari, Bari, Italy
| | - G b Pertosa
- Nephrology Unit, DETO, University of Bari, Bari, Italy
| | - A Gallone
- SMBNOS, University of Bari, Bari, Italy
| | - G Castellano
- Nephrology Unit, DETO, University of Bari, Bari, Italy
| | - L Gesualdo
- Nephrology Unit, DETO, University of Bari, Bari, Italy
| | - F Sallustio
- Nephrology Unit, DETO, University of Bari, Bari, Italy
| |
Collapse
|
17
|
Carella AM, Giordano D, Santini G, Frassoni F, Podestà M, Van Lint MT, Bacigalupo A, Nati S, Vimercati R, Occhini D, Bistolfi F, Lucarelli G, Lercari G, Marmont AM. High Dose BCNU Followed by Autologous Bone Marrow Infusion in Glioblastoma Multiforme. Tumori 2018; 67:473-5. [PMID: 6275588 DOI: 10.1177/030089168106700513] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Four patients with glioblastoma multiforme were treated with high dose BCNU, 800 mg/m2, and autologous marrow transplantation. Two patients were treated in their first and 2 in their second remission. All patients are alive between 1 and 12 months from transplantation.
Collapse
|
18
|
Affiliation(s)
| | - U. Butturini
- Istituto di Semeiotica Medica, Universita di Parma, Italy
| |
Collapse
|
19
|
Castellano G, Intini A, Stasi A, Divella C, Gigante M, Pontrelli P, Franzin R, Accetturo M, Zito A, Fiorentino M, Montinaro V, Lucarelli G, Ditonno P, Battaglia M, Crovace A, Staffieri F, Oortwijn B, van Amersfoort E, Pertosa G, Grandaliano G, Gesualdo L. Complement Modulation of Anti-Aging Factor Klotho in Ischemia/Reperfusion Injury and Delayed Graft Function. Am J Transplant 2016; 16:325-33. [PMID: 26280899 DOI: 10.1111/ajt.13415] [Citation(s) in RCA: 68] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2015] [Revised: 05/31/2015] [Accepted: 06/02/2015] [Indexed: 01/25/2023]
Abstract
Klotho is an anti-aging factor mainly produced by renal tubular epithelial cells (TEC) with pleiotropic functions. Klotho is down-regulated in acute kidney injury in native kidney; however, the modulation of Klotho in kidney transplantation has not been investigated. In a swine model of ischemia/reperfusion injury (IRI), we observed a remarkable reduction of renal Klotho by 24 h from IRI. Complement inhibition by C1-inhibitor preserved Klotho expression in vivo by abrogating nuclear factor kappa B (NF-kB) signaling. In accordance, complement anaphylotoxin C5a led to a significant down-regulation of Klotho in TEC in vitro that was NF-kB mediated. Analysis of Klotho in kidneys from cadaveric donors demonstrated a significant expression of Klotho in pre-implantation biopsies; however, patients affected by delayed graft function (DGF) showed a profound down-regulation of Klotho compared with patients with early graft function. Quantification of serum Klotho after 2 years from transplantation demonstrated significant lower levels in DGF patients. Our data demonstrated that complement might be pivotal in the down-regulation of Klotho in IRI leading to a permanent deficiency after years from transplantation. Considering the anti-senescence and anti-fibrotic effects of Klotho at renal levels, we hypothesize that this acquired deficiency of Klotho might contribute to DGF-associated chronic allograft dysfunction.
Collapse
Affiliation(s)
- G Castellano
- Nephrology, Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy
| | - A Intini
- Nephrology, Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy
| | - A Stasi
- Nephrology, Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy
| | - C Divella
- Nephrology, Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy
| | - M Gigante
- Nephrology, Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy
| | - P Pontrelli
- Nephrology, Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy
| | - R Franzin
- Nephrology, Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy
| | - M Accetturo
- Nephrology, Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy
| | - A Zito
- Nephrology, Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy
| | - M Fiorentino
- Nephrology, Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy
| | - V Montinaro
- Nephrology, Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy
| | - G Lucarelli
- Urology, Andrology and Renal Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy
| | - P Ditonno
- Urology, Andrology and Renal Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy
| | - M Battaglia
- Urology, Andrology and Renal Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy
| | - A Crovace
- Veterinary Surgery Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy
| | - F Staffieri
- Veterinary Surgery Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy
| | - B Oortwijn
- Pharming Group NV, Leiden, the Netherlands
| | | | - G Pertosa
- Nephrology, Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy
| | - G Grandaliano
- Nephrology, Dialysis and Transplantation Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy
| | - L Gesualdo
- Nephrology, Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy
| |
Collapse
|
20
|
Sasanelli N, Vovlas N, Cantalapiedra-Navarrete C, Lucarelli G, Palomares-Rius JE, Castillo P. Parasitism and pathogenicity of curly-leaf parsley with the root-knot nematode Meloidogyne javanica in Southern Italy. Helminthologia 2015. [DOI: 10.1515/helmin-2015-0055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Summary
Severe infections of parsley plants and soil infestations with Meloidogyne javanica during an autumn surveys for the pathogenic root-knot nematode infestations were found in Monopoli at Bari province in Southern Italy. This unusual severe infection of parsley, considered a winter crop, was possibly instigated by a very warm autumn from the previous year. Nematodes were extracted from soil samples according to the Coolen’s method. Morphological analysis (based on stylet length, tail length and shape, adult females perineal pattern, excretory pore position and Ep/stylet ratio) and molecular studies were used for the nematode characterization and identification. In the soil of infested area a severely deformed root systems were observed, showing a galling rate = 2.5 - 4 (scale 0-5) and a soil nematode population densities ranging from 350 to 2,730 eggs and J2 per 5 g of fresh root. M. javanica attack on parsley roots is a limiting factor for plant growth. Considering that curly-leaf parsley varieties resistant to the nematodes are not yet available control strategies must be focused on reduction of soil infestation level below tolerance limit of the target nematode species. Due to the higher cost and reduced availability of fumigant and non-fumigant nematicides, soil solarization, organic amendments or biological control approaches should be preferably used as alternatives.
Collapse
Affiliation(s)
- N. Sasanelli
- Istituto per la Protezione Sostenibile delle Piante (IPSP), Consiglio Nazionale delle Ricerche (CNR), U.O.S. di Bari, Via G. Amendola 122/D, 70126 Bari, Italy
| | - N. Vovlas
- Istituto per la Protezione Sostenibile delle Piante (IPSP), Consiglio Nazionale delle Ricerche (CNR), U.O.S. di Bari, Via G. Amendola 122/D, 70126 Bari, Italy
| | - C. Cantalapiedra-Navarrete
- Instituto de Agricultura Sostenible (IAS), Consejo Superior de Investigaciones Científi cas (CSIC), Apdo. 4084, 14080 Córdoba, Campus de Excelencia Internacional Agroalimentario, cei A3, Spain
| | - G. Lucarelli
- HortoService, Servizi Tecnici in Agricoltura Via S. Pietro 3, 70016 Noicattaro; Bari, Italy
| | - J. E. Palomares-Rius
- Instituto de Agricultura Sostenible (IAS), Consejo Superior de Investigaciones Científi cas (CSIC), Apdo. 4084, 14080 Córdoba, Campus de Excelencia Internacional Agroalimentario, cei A3, Spain
| | - P. Castillo
- Instituto de Agricultura Sostenible (IAS), Consejo Superior de Investigaciones Científi cas (CSIC), Apdo. 4084, 14080 Córdoba, Campus de Excelencia Internacional Agroalimentario, cei A3, Spain
| |
Collapse
|
21
|
Testi M, Battarra M, Lucarelli G, Isgro A, Morrone A, Akinyanju O, Wakama T, Nunes JM, Andreani M, Sanchez-Mazas A. HLA-A-B-C-DRB1-DQB1 phased haplotypes in 124 Nigerian families indicate extreme HLA diversity and low linkage disequilibrium in Central-West Africa. ACTA ACUST UNITED AC 2015; 86:285-92. [DOI: 10.1111/tan.12642] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2014] [Revised: 06/18/2015] [Accepted: 07/20/2015] [Indexed: 12/01/2022]
Affiliation(s)
- M. Testi
- Laboratory of Immunogenetics and Transplant Biology, IME Foundation; Policlinic of the University of Tor Vergata; Rome Italy
| | - M. Battarra
- Laboratory of Immunogenetics and Transplant Biology, IME Foundation; Policlinic of the University of Tor Vergata; Rome Italy
| | - G. Lucarelli
- International Center for Transplantation in Thalassemia and Sickle Cell Anemia, IME Foundation; Policlinic of the University of Tor Vergata; Rome Italy
| | - A. Isgro
- International Center for Transplantation in Thalassemia and Sickle Cell Anemia, IME Foundation; Policlinic of the University of Tor Vergata; Rome Italy
| | - A. Morrone
- International Center for Transplantation in Thalassemia and Sickle Cell Anemia, IME Foundation; Policlinic of the University of Tor Vergata; Rome Italy
| | | | | | - J. M. Nunes
- Laboratory of Anthropology, Genetics and Peopling History, Department of Genetics and Evolution-Anthropology Unit; University of Geneva; Geneva Switzerland
| | - M. Andreani
- Laboratory of Immunogenetics and Transplant Biology, IME Foundation; Policlinic of the University of Tor Vergata; Rome Italy
| | - A. Sanchez-Mazas
- Laboratory of Anthropology, Genetics and Peopling History, Department of Genetics and Evolution-Anthropology Unit; University of Geneva; Geneva Switzerland
| |
Collapse
|
22
|
Grossi V, Lucarelli G, Matrone A, Forte G, Germani A, Rutigliano M, Stella A, Bagnulo R, Loconte D, Galleggiante V, Sanguedolce F, Cagiano S, Bufo P, Trabucco S, Ditonno P, Battaglia M, Resta N, Simone C. 401 Loss of LKB1/STK11 expression is an early event in prostate cancer development and predicts therapeutic response to p38α inhibitor. ACTA ACUST UNITED AC 2015. [DOI: 10.1016/s1569-9056(15)60395-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
23
|
Testi M, Andreani M, Locatelli F, Arcese W, Troiano M, Battarra M, Gaziev J, Lucarelli G. Influence of the HLA characteristics of Italian patients on donor search outcome in unrelated hematopoietic stem cell transplantation. ACTA ACUST UNITED AC 2014; 84:198-205. [DOI: 10.1111/tan.12355] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2013] [Revised: 03/11/2014] [Accepted: 03/19/2014] [Indexed: 11/28/2022]
Affiliation(s)
- M. Testi
- Laboratory of Immunogenetics and Transplant Biology; IME Foundation at Polyclinic of Tor Vergata; Rome Italy
| | - M. Andreani
- Laboratory of Immunogenetics and Transplant Biology; IME Foundation at Polyclinic of Tor Vergata; Rome Italy
| | - F. Locatelli
- Department of Pediatric Hematology-Oncology, IRCCS Bambino Gesù Children's Hospital; University of Pavia; Rome Italy
| | - W. Arcese
- Rome Transplant Network, Department of Hematology, Stem Cell Transplant Unit; Tor Vergata University; Rome Italy
| | - M. Troiano
- Laboratory of Immunogenetics and Transplant Biology; IME Foundation at Polyclinic of Tor Vergata; Rome Italy
| | - M. Battarra
- Laboratory of Immunogenetics and Transplant Biology; IME Foundation at Polyclinic of Tor Vergata; Rome Italy
| | - J. Gaziev
- Rome Transplant Network, Department of Hematology, Stem Cell Transplant Unit; Tor Vergata University; Rome Italy
| | - G. Lucarelli
- International Center for Transplantation in Thalassemia and Sickle Cell Anemia; IME Foundation at Polyclinic of Tor Vergata; Rome Italy
| |
Collapse
|
24
|
Andreani M, Testi M, Lucarelli G. Mixed chimerism in haemoglobinopathies: from risk of graft rejection to immune tolerance. ACTA ACUST UNITED AC 2014; 83:137-46. [DOI: 10.1111/tan.12313] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Affiliation(s)
- M. Andreani
- Laboratory of Immunogenetics and Transplant Biology; IME Foundation at Polyclinic of Tor Vergata; Rome Italy
| | - M. Testi
- Laboratory of Immunogenetics and Transplant Biology; IME Foundation at Polyclinic of Tor Vergata; Rome Italy
| | - G. Lucarelli
- International Center for Transplantation in Thalassemia and Sickle Cell Anemia; IME Foundation at Polyclinic of Tor Vergata; Rome Italy
| |
Collapse
|
25
|
Impedovo SV, De Lorenzis E, Volpe A, Gesualdo L, Grandaliano G, Palazzo S, Lucarelli G, Bettocchi C, Terrone C, Stratta P, Quaglia M, Battaglia M, Ditonno P. Middle and long-term outcomes of dual kidney transplant: a multicenter experience. Transplant Proc 2013; 45:1237-41. [PMID: 23622667 DOI: 10.1016/j.transproceed.2013.02.031] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
INTRODUCTION Dual kidney transplantation (DKTx) to reduce the disparity between demand and supply of organs was evaluated in two Italian centers (Bari and Novara). MATERIALS AND METHODS Between October 2000 and October 2011, we performed 97 DKT (26 ipsilateral/71 bilateral) following routine biopsy of all kidneys obtained from expanded criteria donors by Remuzzi-Karpinsky scores. The reference group was 379 single grafts from donors older than 60 years single kidney transplantation ([SKT] × > 60). RESULTS Good postoperative renal function was observed in 56 DKTx (57.7%); whereas acute tubular necrosis requiring dialysis was observed in 41 (42.3%) patients. After a mean follow-up of 60 months, DKTx graft survivals were 96%, 93%, and 90% and patient survivals, 96%, 91%, and 91% at 1, 3, and 5 years, respectively. Complications in expanded criteria donor kidney transplantations included a high rate of cytomegalovirus (CMV) disease especially dual kidney cases. DKTx represented the only independent risk factor for CMV disease upon multivariate analysis (odds ratio [OR] 2.33, 95% confidence interval [CI] 1.28-4.2; P = .006). We did not observe any significant difference in graft or patient survival between DKTx and SKTx > 60 years. CONCLUSIONS We observed good outcomes up to 5 years after transplantation in terms of graft and patient survival despite the use of inferior grafts. Comparing DKTx and SKT > 60, we noted that the mean Karpinski score for SKTx was significantly better than DKTx, although patient and graft survivals were similar. This trend confirms that the use of a biopsy to allocate expanded criteria donor kidneys may be too protective; therefore, the criteria to select DKTx require further refinement.
Collapse
Affiliation(s)
- S V Impedovo
- Urology, Andrology and Kidney Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Lucarelli G, Breda A. Prone and supine percutaneous nephrolithotomy. MINERVA UROL NEFROL 2013; 65:93-99. [PMID: 23703096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
Since the first successful stone extraction through a nephrostomy in 1976, percutaneous nephrolithotomy (PCNL) has became the preferred procedure especially for treatment of large, complex and staghorn calculi. For decades this method has been performed with the patient in the prone position. More recently, particular interest has been taken on supine PCNL due to less anestesiological risks and the possibility of simultaneous anterograde and retrograde access to the whole urinary tract. Although many retrospective studies have been published, only two prospective trials comparing the two positions are reported in the literature. The best access to PCNL represents still a controversial issue. The overall experience reported in literature indicates that each modality is equally feasible and safe. Therefore, to date the surgeon's preference is the prime indication to one access over the other.
Collapse
Affiliation(s)
- G Lucarelli
- Department of Urology, Fundació Puigvert Barcelona, Spain.
| | | |
Collapse
|
27
|
Vavallo A, Lucarelli G, Bettocchi C, Tedeschi M, Palazzo S, Losappio V, Gesualdo L, Grandaliano G, Selvaggi FP, Battaglia M, Ditonno P. Allograft nephrectomy: what is the best surgical technique? Transplant Proc 2013; 44:1922-5. [PMID: 22974872 DOI: 10.1016/j.transproceed.2012.06.011] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
BACKGROUND The objective of this study was to evaluate differences in outcomes of allograft nephrectomies performed by extracapsular versus intracapsular techniques. METHODS From 1993 to 2010, we performed 89 allograft nephrectomies, including 57 by extracapsular techniques and 32 by intracapsular, chosen according to feasibility at the beginning of the surgery. Fisher exact test and logistic regression were used for statistical analysis. Survival estimates after allograft nephrectomy were calculated according to the Kaplan-Meier method. RESULTS After a mean graft survival of 49.7 months, the indications for transplant nephrectomy were chronic rejection (39.3%), acute rejection (22.5%), infection/sepsis (19.1%), gross hematuria (6.7%), renal vein thrombosis (6.7%), renal artery thrombosis (3.4%), and graft rupture (2.3%). Mean operative time, blood loss, transfusions, and complications were similar between the extracapsular and intracapsular groups. The only difference in surgical aspects between the 2 groups was the mean hospital stay, which was longer for the extracapsular group (13.8 vs 7.6 days; P = .01), a result that was confirmed by multivariate analysis (odds ratio, 1.05; 95% confidence interval, 1.0-1.1; P = .03). CONCLUSIONS Our experience showed no significant advantages in favor of the intracapsular technique except for a shorter length of hospital stay than after the extracapsular procedure.
Collapse
Affiliation(s)
- A Vavallo
- Urology, Andrology, and Kidney Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Sizzano F, Testi M, Zito L, Crocchiolo R, Troiano M, Mazzi B, Turchiano G, Torchio M, Pultrone C, Gregori S, Chiesa R, Gaziev J, Sodani P, Marktel S, Amoroso A, Roncarolo MG, Lucarelli G, Ciceri F, Andreani M, Fleischhauer K. Genotypes and haplotypes in the 3' untranslated region of the HLA-G gene and their association with clinical outcome of hematopoietic stem cell transplantation for beta-thalassemia. ACTA ACUST UNITED AC 2012; 79:326-32. [PMID: 22489942 DOI: 10.1111/j.1399-0039.2012.01862.x] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Polymorphisms in the 3' untranslated region (3'UTR) of HLA-G, an important player in immunological tolerance, could be involved in post-transcriptional expression control, and their association with different clinical immune-related conditions including autoimmunity and transplantation is of mounting interest. Most studies have focused on a 14 base pair (bp) insertion/deletion (ins/del), while additional single-nucleotide polymorphisms (SNPs) in the HLA-G 3'UTR have been described but not extensively investigated for their clinical relevance. Here we have comparatively studied the association between 3'UTR haplotypes of HLA-G, or the 14 bp ins/del, with clinical outcome of HLA-identical sibling hematopoietic stem cell transplantation (HSCT) in 147 Middle Eastern beta-thalassemia patients. Sequence based typing of 3'UTR HLA-G polymorphisms in the patients and in 102 healthy Italian blood donors showed strong linkage disequilibrium between the 14 bp ins/del and five 3'UTR SNPs, which together could be arranged into eight distinct haplotypes based on expectation-maximization studies, with four predominant haplotypes (UTRs1-4). After HSCT, we found a moderate though not significant association between the presence of UTR-2 in double dose and protection from acute graft versus host disease (hazard ratio (HR) 0.45, 95% confidence intervals (CI): 0.14-1.45; P = 0.18), an effect that was also seen when the corresponding 14 bp ins/ins genotype was considered alone (HR 0.42, 95% CI: 0.16-1.06; P = 0.07). No association was found with rejection or survival. Taken together, our data show that there is no apparent added value of considering entire 3'UTR HLA-G haplotypes for risk prediction after allogeneic HSCT for beta-thalassemia.
Collapse
Affiliation(s)
- F Sizzano
- Unit of Molecular and Functional Immunogenetics, Division of Regenerative Medicine, Stem Cells and Gene Therapy, San Raffaele Scientific Institute, Milan, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
29
|
Bussolati B, Moggio A, Collino F, Grange C, Camussi G, Cantaluppi V, Gatti S, Medica D, Figliolini F, Bruno S, Deregibus MC, Sordi A, Biancone L, Tetta C, Segoloni GP, Camussi G, Castellano G, Curci C, Stasi A, Cariello M, Loverre A, Simone S, Tataranni T, Ditonno P, Lucarelli G, Battaglia M, Crovace A, Staffieri F, Gesualdo L, Schena FP, Grandaliano G, Kim S, Heo NJ, Lee JW, Oh YK, Na KY, Joo KW, Earm JH, Han JS, Loureiro J, Aguilera A, Selgas R, Sandoval P, Albar-Vizcaino P, Perez-Lozano ML, Ruiz-Carpio V, Borras-Cuesta F, Dotor J, Lopez-Cabrera M, Henley C, Davis J, Lee P, Wong S, Salyers K, Wagner M, Jung J, Nguyen H, van der Valk M, Jackson J, Serafino R, Jin L, Willcockson M, Ward S, Turk J, Lu JYL, Fu A, Richards W, Reagan JD, Medina J, Li AR, Liu J. Experimental models. Clin Kidney J 2011. [DOI: 10.1093/ndtplus/4.s2.7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
30
|
Ditonno P, Lucarelli G, Impedovo SV, Spilotros M, Grandaliano G, Selvaggi FP, Bettocchi C, Battaglia M. Obesity in kidney transplantation affects renal function but not graft and patient survival. Transplant Proc 2011; 43:367-72. [PMID: 21335224 DOI: 10.1016/j.transproceed.2010.12.022] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
INTRODUCTION The number of overweight and obese patients undergoing renal transplantation has increased dramatically over the past two decades. Studies on graft survival and posttransplantation complications have often yielded conflicting results. Some authors have reported similar results for graft and patient survivals between obese and normal weight patients, but with a marginally increased rate of postoperative complications. In contrast, other reports note higher percentage of graft losses as well as increased mortality. In our study, we analyzed early- and long-term outcomes among obese versus nonobese kidney transplant recipients. PATIENTS AND METHODS Between January 2000 and December 2008, we performed 563 cadaveric kidney transplantations. Recipients were classified in 1 of 5 groups based on their body mass index (BMI) at the time of transplantation: group A (n = 68; BMI < 18.5); group B (n = 310; 18.6 < BMI < 24.9); group C (n = 143; 25 < BMI < 29.9); group D (n = 32; 30 < BMI < 34.9); and group E (n = 10; BMI ≥ 35). The comparative analysis included patient and graft survivals, postoperative complications, onset of delayed graft function (DGF), acute rejection episodes, hospital stay, and serum creatinine values in the first 3 years posttransplantation. RESULTS At a mean follow-up of 53 months (range, 3-112 months), DGF was observed in 20 patients in group A (29.4%), 82 in group B (26.4%), 43 in group C (30%), 16 in group D (50%), and 4 in group E (40%). Nevertheless, obese patients (groups D and E) showed higher mean serum creatinine values and worse renal function at 6 months (P = .001), 1 year (P < .001), and 3 years (P = .001). Moreover, they were at increased risk of an acute rejection episode (P = .01) and more susceptible to cardiovascular and metabolic complications (P = .01). Morbidly obese patients displayed a higher incidence of postsurgical complications (P = .002). There were no differences in the incidences of chronic allograft nephropathy (CAN) or infectious complications. Despite the differences in morbidity among the 5 groups, we failed to observe significant differences in patient or graft survivals at 6, 12, 36, or 60 months. CONCLUSION Our findings suggested that obese patients should not be discriminated against simply based on the BMI. At our center, obese (BMI >35) transplantation candidates undergo a thorough cardiac evaluation, as well as pulmonary, endocrine, and nutritional counseling seeking to minimize medical and surgical complications and improve survival and quality of life.
Collapse
Affiliation(s)
- P Ditonno
- Urology, Andrology and Kidney Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy
| | | | | | | | | | | | | | | |
Collapse
|
31
|
Lucarelli G, Gaziev J, Isgrò A, Sodani P, Paciaroni K, Alfieri C, De Angelis G, Marziali M, Simone MD, Gallucci C, Roveda A, Saltarelli F, Torelli F, Andreani M. Allogeneic cellular gene therapy in hemoglobinopathies—evaluation of hematopoietic SCT in sickle cell anemia. Bone Marrow Transplant 2011; 47:227-30. [DOI: 10.1038/bmt.2011.79] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
32
|
Vavallo A, Lucarelli G, Tedeschi M, Impedovo S, Rutigliano M, Bettocchi C, Selvaggi F, Battaglia M, Ditonno P. 397 DIABETES MELLITUS IS A RISK FACTOR FOR RECURRENCE AND MORTALITY IN PATIENTS WITH RENAL CELL CARCINOMA. ACTA ACUST UNITED AC 2011. [DOI: 10.1016/s1569-9056(11)60391-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
33
|
Lucarelli G, Bettocchi C, Battaglia M, Impedovo S, Vavallo A, Grandaliano G, Castellano G, Schena F, Selvaggi F, Ditonno P. Extended Criteria Donor Kidney Transplantation: Comparative Outcome Analysis Between Single versus Double Kidney Transplantation at 5 Years. Transplant Proc 2010; 42:1104-7. [DOI: 10.1016/j.transproceed.2010.03.059] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
34
|
Bettocchi C, Palumbo F, Spilotros M, Lucarelli G, Ricapito V, Palazzo S, Battaglia M, Selvaggi F, Ditonno P. Penile prosthesis implant: when, what and how. Journal of Men's Health 2009. [DOI: 10.1016/j.jomh.2009.09.033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
35
|
Roveda A, Sodani P, Paciaroni K, Gallucci C, Lucarelli G, Tenze G. Recurrent Deep Vein Thrombosis after the Insertion of Two Vascular Accesses in a 13-year-old Thalassemic Girl Waiting for a Haploidentical Marrow Transplant. J Vasc Access 2009; 10:64-5. [DOI: 10.1177/112972980901000113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Affiliation(s)
- A. Roveda
- MIH Foundation-Mediterranean Institute of Haematology, International Center for Transplantation in Thalassemia and Sickle cell Anemia, Policlinico Tor Vergata, Roma - Italy
| | - P. Sodani
- MIH Foundation-Mediterranean Institute of Haematology, International Center for Transplantation in Thalassemia and Sickle cell Anemia, Policlinico Tor Vergata, Roma - Italy
| | - K. Paciaroni
- MIH Foundation-Mediterranean Institute of Haematology, International Center for Transplantation in Thalassemia and Sickle cell Anemia, Policlinico Tor Vergata, Roma - Italy
| | - C. Gallucci
- MIH Foundation-Mediterranean Institute of Haematology, International Center for Transplantation in Thalassemia and Sickle cell Anemia, Policlinico Tor Vergata, Roma - Italy
| | - G. Lucarelli
- MIH Foundation-Mediterranean Institute of Haematology, International Center for Transplantation in Thalassemia and Sickle cell Anemia, Policlinico Tor Vergata, Roma - Italy
| | - G. Tenze
- Department of Anesthesia and Intensive Care Unit, Policlinico Tor Vergata, Roma - Italy
| |
Collapse
|
36
|
Abstract
SCT still remains the only cure currently available for patients with thalassemia. Results of transplants in this disease have steadily improved over the last two decades due to improvements in preventive strategies, effective control of transplant-related complications and development of new preparative regimens. Currently, high-resolution HLA typing has enabled physicians to perform transplants from unrelated volunteer donors for thalassemia with results comparable with those obtained employing an HLA-identical sibling. The probabilities for obtaining thalassemia-free survival after transplant in thalassemia from an HLA-identical donor, family member or MUD are between 85 and 87%. Therefore, when an HLA-identical donor is present, the transplant of allogeneic stem cell should be performed as allogeneic gene therapy. In the light of advances in transplantation for thalassemia, patients with an HLA-identical donor should be offered SCT.
Collapse
Affiliation(s)
- J Gaziev
- Mediterranean Institute of Hematology, International Center for Transplantation in Thalassemia and Sickle Cell Anemia, Policlinic of the University of Roma Tor Vergata, Roma, Italy
| | | | | |
Collapse
|
37
|
Ditonno P, Lucarelli G, Bettocchi C, Palazzo S, Palella GV, Battaglia M, Selvaggi FP. "Deviceless" hand-assisted laparoscopic donor nephrectomy. Transplant Proc 2008; 40:1829-30. [PMID: 18675063 DOI: 10.1016/j.transproceed.2008.05.033] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
Hand-assisted laparoscopic nephrectomy (HLN) in living donors is a minimally invasive surgical modality that uses classic laparoscopic techniques combined with the surgeon's hand as a support tool during renal dissection. We describe our experience with 14 donors undergoing HLN with a novel "deviceless" technique (DL-HLN). We used a midline or a paramedian incision. The first 10-mm trocar (camera) was inserted near the umbilicus and another 10-mm trocar placed under laparoscopic vision at the level of the anterior axillary line above the iliac crest. DL-HLN was performed in 14 patients (11 women and 3 men) of overall mean age of 40 years (range=33-60). Left nephrectomy was performed in all cases. Mean surgical time was 105 minutes (range=60-150). Estimated blood loss was 50 to 800 mL (mean=200 mL). Mean warm ischemia time was 3.5 minutes (range=2-11). Mean hospital stay was 4 days (range=3-6). In one case, uncontrollable hemorrhage developed due to a renal vein lesion at the level of the adrenal vein outlet, requiring conversion to open surgery. As to graft function, recipient serum creatinine on day 7 ranged from 0.9 to 2.6 mg/dL (mean=1.6). We used no device in our technique. The pneumoperitoneum was maintained by the sealing effect of the muscular fascia around the surgeon's wrist. Moreover, the kidney was removed through the hand port without an Endobag. Our modified HLN technique avoids the use of costly disposables and offers the advantages of a smaller incision.
Collapse
Affiliation(s)
- P Ditonno
- Department of Emergency and Organ Transplantation, Urology and Kidney Transplantation Unit, University of Bari, Bari, Italy.
| | | | | | | | | | | | | |
Collapse
|
38
|
Ditonno P, Lucarelli G, Bettocchi C, Palazzo S, Palella G, Battaglia M, Selvaggi F. Incidentally Discovered Yellowish Lesions in a Renal Graft From a Deceased Donor. Transplant Proc 2008; 40:2062-4. [DOI: 10.1016/j.transproceed.2008.05.027] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
|
39
|
Lucarelli G, Mancini V, Annunziata G, Trabucco S, Palazzo S, Ditonno P, Battaglia M, Selvaggi F. Adult Type Testicular Granulosa Cell Tumor: Case Report and Review of the Literature. Urologia 2006. [DOI: 10.1177/039156030607300307] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Granulosa cell tumors represent a special group of the so-called sex cord-stromal tumors of the gonads, and are divided into 2 histological types: adult and juvenile. Adult type testicular granulosa cell tumor is a rare neoplasia: 22 cases of this testicular tumor only have been described in literature so far. They are often discovered accidentally and exhibit no endocrine-related symptoms. We report a case of adult type granulosa cell tumor in a 45-year-old man likely affected by a 15-year-old painless tumor with increased right testicular size; he underwent radical orchiectomy. This case and a review of the literature indicate that this kind of tumor is a rare, slow-growing neoplasm. Since distant metastases may occur late in the clinical course, long term follow-up of these patients is recommended.
Collapse
Affiliation(s)
- G. Lucarelli
- Dipartimento dell'Emergenza e dei Trapianti d'Organo, Sezione di Urologia e Trapianto di Rene
| | - V. Mancini
- Dipartimento dell'Emergenza e dei Trapianti d'Organo, Sezione di Urologia e Trapianto di Rene
| | - G. Annunziata
- Dipartimento dell'Emergenza e dei Trapianti d'Organo, Sezione di Urologia e Trapianto di Rene
| | - S. Trabucco
- Dipartimento dell'Emergenza e dei Trapianti d'Organo, Sezione di Urologia e Trapianto di Rene
- Dipartimento di Anatomia Patologica e di Genetica, Sezione di Anatomia Patologica II, Università degli Studi di Bari, Bari
| | - S. Palazzo
- Dipartimento dell'Emergenza e dei Trapianti d'Organo, Sezione di Urologia e Trapianto di Rene
| | - P. Ditonno
- Dipartimento dell'Emergenza e dei Trapianti d'Organo, Sezione di Urologia e Trapianto di Rene
| | - M. Battaglia
- Dipartimento dell'Emergenza e dei Trapianti d'Organo, Sezione di Urologia e Trapianto di Rene
| | - F.P. Selvaggi
- Dipartimento dell'Emergenza e dei Trapianti d'Organo, Sezione di Urologia e Trapianto di Rene
| |
Collapse
|
40
|
Manfredi G, Lucarelli G, Derosa C, Ventura E. Relationship between number of allergic sensitizations and immunity impairment: anything new in immunotherapy for allergies and vaccines planning? Eur Ann Allergy Clin Immunol 2005; 37:321-4. [PMID: 17066651] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
Abstract
To 106 14-56 year-old allergic people (30 monosensitized, 24 sensitized to 2 pollens, 52 polysensitized) we have evaluated the Global Immune Competence Status (GICS). That's a compound score, made of ten parameters, six regarding cell-mediated immunity (WBC/mmc, Gr/mmc, Ly/mmc, Ly CD3+/mmc, Ly CD4+/mmc, CD4/CD8 Ratio), four regarding nutritional status and humoral immunity (Tot. Protein mg/dl, Albumin mg/dl, Gammaglobulins mg/dl, IgG mg/dl). Each parameter is brought on a grid including 4 worth scores worsening from 4 to 1, related to different ranges of values; this way quickly leads to characterize type and grade of immune deficiency. So doing we found that in 30 monosensitized people 27 (90%) show a complete immune competence, while just 3 people (10%) have impaired GICS: in these 1 (3%) regards cell-mediated immunity, while 2 (7%) regard humoral immunity. In 24 patients sensitized to 2 allergenes, 18 (75%) showed complete immune competence, while 6 (25%) a GICS impairment regarding cell-mediated immunity. In leaving 52 polysensitized patients, 30 people showed complete immune competence (58%), while 20 (38%) showed a GICS impairment regarding cell-mediated immunity and 2 (4%) impaired humoral immunity. This work shows that the higher the number of sensitizations is, the stronger the cell-mediated immunity impairment in allergic people become.
Collapse
Affiliation(s)
- G Manfredi
- Allergy and Clinical Immunology Unit, Dept. of General and Specialistic Medicine Religious General Regional Hospital F. Miulli, Acquaviva delle Fonti (BA), Italy.
| | | | | | | |
Collapse
|
41
|
Gresele P, Lucarelli G, Mezzasoma AM, Falcinelli E, Guglielmini G. Platelet-derived nitric oxide (NO) is suppressed by hyperhomocysteinemia: a possible prothrombotic effect. J Thromb Haemost 2003. [DOI: 10.1111/j.1538-7836.2003.tb04545.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
42
|
Abstract
In order to determine the influence of HA-1 minor histocompatibility antigen mismatch on BMT outcome, we analyzed a pool of 94 thalassemic transplanted patients all selected for the presence of HLA-A(*)0201 allele. The HA-1 typing was performed using SSP analysis. All the patients received bone marrow from HLA-identical MLC nonresponsive siblings. As graft-versus-host-disease (GVHD) prophylaxis, all patients received cyclosporin and short methotrexate. Grades II-IV GVHD occurred in five (33.3%) of the 15 patients with recipient HA-1 disparity compared with 14 (17.7%) of the 79 patients without HA-1 disparity. Despite the higher incidence of acute graft-versus-host-disease (aGVHD) in the group of patients with HA-1 incompatibility, these data were not statistically significant. However, it was interesting to observe that no GVHD developed in any of the 15 cases in which the recipient was HA-1 negative and the donor HA-1 positive.
Collapse
Affiliation(s)
- S Nesci
- Laboratorio de Ricerca Onco-Ematologico, Dipartimento di Onco Ematologia, Pesaro, Italy
| | | | | | | | | |
Collapse
|
43
|
Ribatti D, Polimeno G, Vacca A, Marzullo A, Crivellato E, Nico B, Lucarelli G, Dammacco F. Correlation of bone marrow angiogenesis and mast cells with tryptase activity in myelodysplastic syndromes. Leukemia 2002; 16:1680-4. [PMID: 12200681 DOI: 10.1038/sj.leu.2402586] [Citation(s) in RCA: 49] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2001] [Accepted: 04/10/2002] [Indexed: 12/14/2022]
Abstract
Bone marrow samples from 30 patients with myelodysplastic syndromes (MDS) grouped according to the International Prognostic Scoring System for MDS were investigated for counts of microvessels, total metachromatic mast cells (MC) and MC expressing tryptase, an angiogenesis-inducing molecule. Counts were higher in patients with a poor prognosis. The observation of a high correlation between microvessel counts and both total metachromatic and tryptase-reactive MC in all samples suggests that angiogenesis in MDS increases with their progression and that MC may intervene in the angiogenic response in MDS through tryptase contained in their secretory granules.
Collapse
Affiliation(s)
- D Ribatti
- Department of Human Anatomy and Histology, University of Bari Medical School, Bari, Italy
| | | | | | | | | | | | | | | |
Collapse
|
44
|
Abstract
Mammalian sperm at ejaculation are suspended in the seminal plasma, a heterogeneous mixture deriving from the testicular/epididymal fluid and from secretions of seminal vesicles, prostate and bulbourethral glands. Biochemical characteristics of seminal fluid change along the male reproductive tract when considering its inorganic and organic composition and pH but it is known that in each region of the male genital tract seminal osmolarity is higher than that of serum. It has been previously demonstrated that in invertebrate and vertebrate sperm, seminal plasma osmolarity influences sperm motility and activity, and human sperm have been shown to possess osmosensitive calcium entry pathway that controls important functions such as acrosome reaction and oocyte penetration. In the present study, we have determined seminal plasma osmolarity in a large number of normozoospermic fertile and asthenozoospermic infertile subjects correlating it with sperm motility percentages and kinematic characteristics determined utilizing a computerized motion analysis system. Our results confirm that seminal plasma osmolarity is higher than that of serum (336.1 +/- 20.2 vs. 291.1 +/- 6.9 mOsm/L, respectively). Normozoospermic subjects show seminal osmolarity values that are significantly lower with respect to asthenozoospermic patients (317.8 +/- 12.2 vs. 345.2 +/- 22.6 mOsm/L, p<0.001), irrespective of the cause of asthenozoospermia. Seminal plasma osmolarity negatively correlates with sperm progressive motility percentages and kinetic characteristics (curvilinear velocity, linear velocity, linear coefficient and lateral displacements of sperm head). Furthermore, when sperm from fertile subjects were suspended in medium with an osmolarity increasing from 300 to 600 mOsm, sperm motility percentages and kinetics characteristics were progressively reduced and nearly abolished when medium osmolarity was 600 mOsm. On the contrary, when sperm from asthenozoospermic subjects with high semen osmolarity were resuspended in medium with lower osmolarity, sperm motility parameters improved significantly. Sperm motility parameters did not correlate with seminal plasma concentrations of sodium, potassium, chloride with a weak correlation only with seminal calcium concentration. No correlations are present between seminal plasma osmolarity and ionic composition. In conclusion, the present study confirms and extends the knowledge that, in human, seminal plasma osmolarity is higher than that of serum and demonstrates that seminal osmolarity influences sperm motility characteristics and then it may contribute to the pathogenesis of some forms of asthenozoospermia and male infertility.
Collapse
Affiliation(s)
- M Rossato
- Department of Medical and Surgical Sciences, Clinica Medica 3, University of Padova, Italy.
| | | | | | | | | |
Collapse
|
45
|
Affiliation(s)
- G Lucarelli
- U.O. Ematologia e Centro Trapianto Midollo Osseo di Muraglia, Azienda Ospedale S. Salvatore di Pesaro, Pesaro, Italy
| | | | | |
Collapse
|
46
|
Gaziev D, Galimberti M, Polchi P, Angelucci E, Giardini C, Baronciani D, Andreani M, Persini B, Erer B, Sodani P, Manna M, Nicolini G, Visani G, Lucarelli G. Fate of chronic myeloid leukemia patients treated with allogeneic bone marrow transplantation or chemotherapy and/or interferon at a single center: long-term results. Bone Marrow Transplant 2002; 29:1-8. [PMID: 11840137 DOI: 10.1038/sj.bmt.1703323] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2001] [Accepted: 10/07/2001] [Indexed: 11/08/2022]
Abstract
From April 1981 to February 2000, 105 patients with chronic myeloid leukemia (CML) underwent BMT from HLA-identical related donors at a single center. Eighty-eight patients were in chronic phase (CP), 11 patients in accelerated phase and six patients in blast crisis. Ten of these patients received a second BMT (BMT2). Comparison of BMT in CP with chemotherapy and/or alpha-IFN (n=70) was also made. Patients were given cyclophosphamide (CY) and single-dose TBI (CYTBI, n=38) or busulfan (BU) and CY (BUCY, n=67). Overall 54 patients are alive and 52 of them are disease-free with a median follow-up of 11.3 (range 1.1-19.4) years. Ten-year disease-free survival (DFS) in CP patients was better after BUCY, 61% (95% CI, 47-68%) than after CYTBI, 41% (95% CI, 23-61%) (P=0.07). For 88 patients who received a transplant in CP, results were significantly improved when BMT was performed within 1 year after diagnosis (P=0.02) or at an age < or = 25 years old (P=0.01). Ten-year survival in patients who received BMT in CP was better than in patients treated with chemotherapy (56% vs 10%; P=0.0001) or alpha-IFN-based treatment (33%; P=0.09) with survival curves crossing at 4.2 years and at 4 years, respectively. The probability of DFS after BMT2 was 60% (95% CI, 26-87%). CP patients who received BMT after CYTBI had a higher probability of relapse and transplant-related mortality than patients receiving BUCY (53% and 58% vs 9% and 34%; P=0.002 and P=0.08, respectively). All but six patients are currently on no medication and have resumed all activities without any limitation. These long-term results confirm that allogeneic BMT is the only curative approach for CML patients and should be offered to all patients with a suitable donor as soon after diagnosis as possible.
Collapse
MESH Headings
- Adolescent
- Adult
- Antineoplastic Combined Chemotherapy Protocols/administration & dosage
- Antineoplastic Combined Chemotherapy Protocols/toxicity
- Bone Marrow Transplantation/methods
- Bone Marrow Transplantation/mortality
- Bone Marrow Transplantation/standards
- Child
- Combined Modality Therapy/adverse effects
- Combined Modality Therapy/mortality
- Disease-Free Survival
- Female
- Follow-Up Studies
- Humans
- Interferons/administration & dosage
- Interferons/toxicity
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive/chemically induced
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive/mortality
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive/therapy
- Male
- Middle Aged
- Prospective Studies
- Survival Analysis
- Transplantation, Homologous/methods
- Transplantation, Homologous/mortality
- Transplantation, Homologous/standards
- Treatment Outcome
Collapse
Affiliation(s)
- D Gaziev
- Unità Operativa di Ematologia e Centro Trapianti di Midollo Osseo di Muraglia, Azienda Ospedaliera S, Salvatore di Pesaro, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Affiliation(s)
- G Lucarelli
- Unità Operativa di Ematologia e Centro Trapianto Midollo Osseo, Azienda Ospedale S. Salvatore, Pesaro, Italy
| | | | | |
Collapse
|
48
|
Abstract
Chronic graft-versus-host disease (cGvHD) continues to be the major problem in long-term survivors of allogeneic haematopoietic stem cell transplants and is the principal cause of morbidity and non-relapse mortality. Over the past twenty years, diagnosis, prophylaxis and treatment of cGvHD have slowly evolved. An effective therapy for cGvHD is designed to prevent complications through targeting the disease mechanisms. None of the present therapies for cGvHD are successful in the majority of patients. Conventional drugs in different combinations can control the disease in approximately 50% of patients. Attempts to improve survival have led to evaluation of several alternative approaches in the treatment of refractory cGvHD with varying degrees of success. Clinical trials are needed to establish the role of these new approaches in the treatment of cGvHD as first line or salvage therapy without causing significant side effects. This review summarises the currently available knowledge on conventional and new treatment approaches for cGvHD.
Collapse
Affiliation(s)
- D Gaziev
- Unità Operativa di Ematologia e Centro Trapianti Midollo Osseo de Muraglia, Azienda Ospedaliera S. Salvatore di Pesaro, Italy
| | | |
Collapse
|
49
|
Abstract
In this paper we report the identification of a new HLA-A*02 allele in two members of an Afghan family. This novel allele, designed as A*02202, differs from A*02201 by a silent substitution at codon 66 (AAC-->AAT) in the alpha1 domain. A*02202 appears to be the result of a novel mutation (Note).
Collapse
Affiliation(s)
- S Nesci
- Divisione di Ematologia e Centro Trapianti Midollo Osseo di Muraglia, Azienda Ospedale "San Salvatore", Pesaro, Italy.
| | | | | | | | | |
Collapse
|
50
|
Gaziev D, Lucarelli G, Polchi P, Angelucci E, Galimberti M, Giardini C, Baronciani D, Erer B, Sodani P. A three or more drug combination as effective therapy for moderate or severe chronic graft-versus-host disease. Bone Marrow Transplant 2001; 27:45-51. [PMID: 11244437 DOI: 10.1038/sj.bmt.1702741] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
We analyzed the results of a three or more drug combination as treatment for moderate or severe cGVHD developing after transplantation for thalassemia, in 45 patients with median age of 11 (range 2-26) years. Eighteen patients received a three drug regimen with cyclosporine (CsA), methylprednisolone (MP) and azathioprine (AZ) as first line therapy, 16 patients received this regimen as salvage therapy and 11 patients were given a four or five drug regimen with CsA, MP, AZ, cyclophosphamide (CY) and/or methotrexate (MTX) mainly as salvage therapy. The overall complete response (CR) rate was 77.3%, with 94% of CR in patients receiving the three drug regimen as first line, 88% in patients receiving it as salvage therapy and 36.6% in patients given the four or five drug regimen. The probability of CR in patients given the three drug regimen as first or salvage therapy or the four/five drug regimen was 89%, 53% and 30%, while the probability of survival was 89%, 65% and 58%, respectively. The incidence of treatment failure was low in our patients. Patients treated with the three drug regimen as first line therapy had less treatment-related complications than patients receiving this regimen as salvage therapy or patients given the four or five drug regimen. The main causes of treatment-related mortality (20%) were infectious complications. This retrospective study showed that a three or more drug combination is safe and effective for treatment of moderate or severe cGVHD at least in younger patients.
Collapse
Affiliation(s)
- D Gaziev
- Divisione di Ematologia e Centro Trapianti di Midollo Osseo di Muraglia, Azienda Ospedaliera S Salvatore di Pesaro, Pesaro, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|